Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSBR | MRNS | CARM | ||
| Company | Champions Oncolog | Marinus Pharma CS | Carisma Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.03 | 1.4200 | 1.7000 | ||
| High | 5.03 | 1.4550 | 1.7000 | ||
| Low | 5.02 | 1.3800 | 1.6000 | ||
| Last | 5.02 | 1.4050 | 1.6400 | ||
| Change | -0.04 | -0.0150 | unch | ||
| % Change | -0.79% | -1.06% | unch | ||
| Volume | 1,600 | 1,136,300 | 54,700 | ||
| 20-Day Average Volume | 2,610 | 4,596,895 | 189,365 | ||
| Previous Close | 5.06 | 1.4200 | 1.6400 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 5.00 | 4.8520 | 1.8320 | ||
| 20-Day Raw Stochastic | 47.66% | 3.71% | 14.29% | ||
| 20-Day Relative Strength | 44.27% | 17.83% | 37.96% | ||
| Weighted Alpha | -9.39 | -38.07 | -58.18 | ||
| Today's Opinion | 88% Sell | 88% Sell | 100% Sell | ||
| Previous Opinion | 88% Sell | 88% Sell | 100% Sell | ||
| Last Month's Opinion | 72% Sell | 24% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.89% since 04/18/24 | +1.81% since 04/19/24 | +0.61% since 04/19/24 | ||
| Low | 5.02 on 04/26/24 | 1.3500 on 04/22/24 | 1.6000 on 04/26/24 | ||
| High | 5.14 on 04/25/24 | 1.5600 on 04/23/24 | 1.9100 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | unch since 03/26/24 | -84.02% since 03/26/24 | -28.70% since 03/26/24 | ||
| Low | 4.76 on 04/08/24 | 1.1100 on 04/16/24 | 1.5300 on 04/19/24 | ||
| High | 5.30 on 04/12/24 | 9.2400 on 03/28/24 | 2.3850 on 03/27/24 | ||
| 3-Month | |||||
| %Chg | -19.74% since 01/26/24 | -85.98% since 01/26/24 | -23.72% since 01/26/24 | ||
| Low | 4.76 on 04/08/24 | 1.1100 on 04/16/24 | 1.5300 on 04/19/24 | ||
| High | 6.26 on 02/06/24 | 10.5000 on 03/01/24 | 2.7700 on 03/01/24 | ||
| 6-Month | |||||
| %Chg | -17.30% since 10/26/23 | -78.94% since 10/26/23 | -42.25% since 10/26/23 | ||
| Low | 4.51 on 12/18/23 | 1.1100 on 04/16/24 | 1.5300 on 04/19/24 | ||
| High | 7.13 on 01/17/24 | 11.2600 on 01/08/24 | 3.4179 on 11/06/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 68,242 | 77,178 | 68,131 | ||
| Shares Outstanding, K | 13,594 | 54,931 | 41,543 | ||
| Annual Sales | 53,870,000 | 30,990,000 | 14,920,000 | ||
| Annual Net Income | -5,340,000 | -141,410,000 | -86,880,000 | ||
| Last Quarter Sales | 12,020,000 | 7,190,000 | 4,290,000 | ||
| Last Quarter Net Income | -2,530,000 | -41,770,000 | -20,960,000 | ||
| 60-Month Beta | 0.39 | 0.91 | 0.95 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.19 on 03/12/24 | -0.74 on 03/05/24 | -0.52 on 04/01/24 | ||
| Latest Earnings Date | 03/20/24 | 05/09/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||